|
|
| Biotechnologies Et Génétique > Etude de marché sectorielle |
| Integrating Genomics: The Next Generation |
|
|
|
|
€ 795,00 |
Editeur
: |
Business Insight |
Langue
: |
Anglais |
Date de publication : |
Février 1999 |
Taille du document : |
124 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (1) |
|
|
|
| 72 pages | Avril 2003 | Anglais
|
|
|
| Main
focus: |
genomics,drug discovery,proteomics,microarray,...,...
|
| Research
focus: |
market size and estimates,demand analysis, |
| Geographic
focus: |
switzerland,usa,austria,japan,germany,france,... |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
03-038: Clinical Proteomics: A First-Glance Market Report
96 pages | Septembre 2003 |
his First-Glance Market Report identifies the research objectives, methodologies, assay parameters and technological limitations that are currently associated with disease-based protein-profiling stud |
400,00 €
|
| |
| |
Carbohydrate Therapeutics
180 pages | Décembre 2000 |
Carbohydrates are the only class of biological molecule (there are four main classes: nucleic acids, proteins, lipids, and carbohydrates - commonly known as sugars), that can be found in direct associ |
1 400,00 €
|
| |
| |
Bioinformatics IR
pages | Juillet 2001 |
There is little doubt that biology is going large-scale.
Great leaps in high throughput technologies fueled by the genome sequencing projects, gene expression analysis and proteomics, to name but a |
1 600,00 €
|
| |
| |
Revolutionise Drug Discovery through Genomics & Proteomics Study
10 pages | Novembre 2002 |
Genomics and Proteomics are complementary technologies of biological research.
The potential of these technologies for biomedical revolution will be realized by integrating them into the drug disc |
200,00 €
|
| |
| |
Nanotechnology: Emerging Trends
30 pages | Avril 2003 |
Recently, nanotechnology has become extremely popular and is used to describe many types of research where the characteristic dimensions are less than about 1,000 nanometers.
Nanotechnology also pr |
550,00 €
|
| |
| |
The Pharmacogenomics Outlook
174 pages | Août 2000 |
Pharmaceutical companies are coming under increasing pressure to increase the quality of their products, and optimize and accelerate drug discovery and development.
By identifying differenc |
955,00 €
|
| |
| |
Integrating Genomics: The Next Generation
124 pages | Février 1999 |
Genomics research : Understand the key technologies including target identification (genome mapping, random sequencing and two-hybrid assay), target validation/assay development and current appli |
795,00 €
|
| |
| |
Biotechnology Business and Market Analysis
30 pages | Octobre 2002 |
The growing biotechnology industry and its sectors like – agriculture, marine sciences, human therapeutics, and the environment are aiding long-term economic growth.
Biotechnology is creating new p |
500,00 €
|
| |
| |
Lead Validation Platforms IRCD
pages | Juillet 2001 |
The advent of brute force approaches to lead generation has highlighted a key bottleneck in drug development.
The issue is not how many new compounds can one make per day, but rather how many c |
1 200,00 €
|
| |
| |
Strategies for Biogeneric Success
71 pages | Juin 2004 |
What will determine success? Development of biogeneric molecules for sale in the potentially highly lucrative US and Western European markets depends on the ability to answer three key questions |
1 500,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Integrating Genomics: The Next Generation |
|
|
Genomics research :
Understand the key technologies including target identification (genome mapping,
random sequencing and two-hybrid assay), target validation/assay development
and current applications.
Key players :
Identify the leading players in the genomics market and understand the drivers
for consolidation within the biotechnology sector as well as the role of pharmaceutical
companies
The future :
Identify future issues surrounding the impact of genomics on drug research,
development and disease management and identify new market opportunities.
|
|
CHAPTER 1: INTRODUCTION
CHAPTER 2: GENOMIC RESEARCH: UNDERSTANDING THE TECHNOLOGY
CHAPTER 3: CURRENT APPLICATIONS
CHAPTER 4: KEY PLAYERS IN GENOMIC RESEARCH
CHAPTER 5: FUTURE ISSUES REGARDING GENOMICS
CHAPTER 6: APPENDIX
|
|
|
PPLSEN
|
|
|
|
|
